BMRN vs S · P/E 40, rev $2.85B vs rev $821.5M
Biomarin Pharmaceutical Inc (BMRN) versus SentinelOne Inc (S) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
SentinelOne Inc (S) is a software - infrastructure company listed on NYSE.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported S revenue for 2025-01-31 was $821.5M. Net income was -$288.4M. Revenue was up 32.2% from 2024-01-31 to 2025-01-31. S currently screens at market cap $4.99B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. S currently screens at market cap $4.99B.
Not investment advice. Open the BMRN and S stock pages for the full models.
Not investment advice.